$4.49
-0.06-1.32%
At close: -
$4.55
0.061.34%
After Hours: Dec 24, 1:24 PM EDT
Comments
Loading...
Journey Medical (NASDAQ:DERM) Stock, Analyst Ratings, Price Targets, Forecasts
Journey Medical Corp has a consensus price target of $8.75 based on the ratings of 6 analysts. The high is $11 issued by Roth MKM on June 28, 2024. The low is $6 issued by B. Riley Securities on September 7, 2023. The 3 most-recent analyst ratings were released by Lake Street, Rodman & Renshaw, and Roth MKM on September 6, 2024, August 22, 2024, and June 28, 2024, respectively. With an average price target of $9.67 between Lake Street, Rodman & Renshaw, and Roth MKM, there's an implied 112.45% upside for Journey Medical Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Lake Street
Rodman & Renshaw
Roth MKM
Alliance Global Partners
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for Journey Medical
Data brought to you by Benzinga APIs
FAQ
What is the target price for Journey Medical (DERM) stock?
The latest price target for Journey Medical (NASDAQ:DERM) was reported by Lake Street on September 6, 2024. The analyst firm set a price target for $9.00 expecting DERM to rise to within 12 months (a possible 97.80% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Journey Medical (DERM)?
The latest analyst rating for Journey Medical (NASDAQ:DERM) was provided by Lake Street, and Journey Medical initiated their buy rating.
When was the last upgrade for Journey Medical (DERM)?
There is no last upgrade for Journey Medical
When was the last downgrade for Journey Medical (DERM)?
There is no last downgrade for Journey Medical.
When is the next analyst rating going to be posted or updated for Journey Medical (DERM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Journey Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Journey Medical was filed on September 6, 2024 so you should expect the next rating to be made available sometime around September 6, 2025.
Is the Analyst Rating Journey Medical (DERM) correct?
While ratings are subjective and will change, the latest Journey Medical (DERM) rating was a initiated with a price target of $0.00 to $9.00. The current price Journey Medical (DERM) is trading at is $4.55, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.